Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › LOS ANGELES › UCLA RADIOLOGY MEDICAL GROUP

UCLA RADIOLOGY MEDICAL GROUP

NPI: 1881670248 · LOS ANGELES, CA 90095 · Body Imaging Physician · NPI assigned 12/19/2005

$11.44M
Total Medicaid Paid
422,810
Total Claims
323,713
Beneficiaries
118
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialENZMANN, DIETER (DEPARTMENT CHAIRMAN)
NPI Enumeration Date12/19/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 44,085 $653K
2019 43,075 $746K
2020 51,728 $1.08M
2021 65,079 $1.59M
2022 61,831 $1.86M
2023 77,853 $2.74M
2024 79,159 $2.78M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 10,306 8,838 $1.34M
74177 Computed tomography, abdomen and pelvis; with contrast material 16,066 15,003 $1.23M
71045 Radiologic examination, chest; single view 172,796 107,798 $1.16M
78815 Positron emission tomography (PET) for limited area imaging 1,025 980 $1.07M
70450 Computed tomography, head or brain; without contrast material 32,415 28,209 $871K
74183 3,093 3,022 $523K
71250 9,444 9,002 $436K
74178 3,342 3,245 $411K
71260 Computed tomography, thorax, diagnostic; with contrast material 7,295 7,025 $373K
74176 Computed tomography, abdomen and pelvis; without contrast material 5,037 4,686 $281K
71275 Computed tomographic angiography, chest, with contrast material 3,788 3,623 $253K
70551 Magnetic resonance imaging, brain; without contrast material 3,347 3,084 $253K
71046 Radiologic examination, chest; 2 views 27,040 24,688 $243K
74018 25,700 17,420 $190K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 836 832 $161K
72197 770 760 $161K
76700 Ultrasound, abdominal, real time with image documentation; complete 3,537 3,502 $134K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 1,497 1,488 $133K
93970 2,546 2,295 $123K
76770 3,501 3,417 $109K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 746 661 $98K
72141 870 864 $85K
A9581 Injection, gadoxetate disodium, 1 ml 774 768 $84K
72125 Computed tomography, cervical spine; without contrast material 2,378 2,324 $84K
A9585 Injection, gadobutrol, 0.1 ml 6,592 4,250 $83K
77067 Screening mammography, bilateral, including computer-aided detection 1,373 1,372 $82K
76642 1,496 1,225 $71K
99152 2,900 2,644 $71K
74174 748 676 $69K
70491 1,428 1,406 $65K
76705 Ultrasound, abdominal, real time with image documentation; limited 2,874 2,663 $64K
70486 1,051 1,034 $62K
70496 778 737 $53K
93971 2,141 1,954 $47K
93976 834 780 $47K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 8,182 5,506 $46K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1,147 1,124 $45K
49083 409 239 $45K
76830 Ultrasound, transvaginal 1,012 995 $43K
76536 1,289 1,284 $43K
70498 693 659 $42K
75574 220 219 $38K
77065 Tomosynthesis, mammo 492 462 $35K
73030 4,064 3,427 $35K
73221 241 218 $31K
73562 3,744 2,824 $30K
73130 3,180 2,250 $28K
77063 Screening digital breast tomosynthesis, bilateral 1,129 1,127 $27K
73630 3,069 2,422 $26K
99223 Prolong inpt eval add15 m 332 326 $25K
72110 1,214 1,210 $24K
73502 2,620 2,478 $23K
77066 Tomosynthesis, mammo 192 191 $21K
93880 308 308 $21K
73610 2,203 1,820 $20K
72100 1,411 1,374 $16K
36558 146 140 $15K
73564 1,549 1,075 $14K
73110 1,753 1,415 $14K
76937 1,438 1,251 $14K
72156 80 78 $14K
72158 104 101 $13K
76776 617 544 $13K
77001 692 663 $12K
99232 Subsequent hospital care, per day, moderate complexity 295 188 $11K
76377 464 458 $10K
73590 1,370 1,150 $9K
73560 1,790 1,430 $9K
76882 454 396 $8K
73523 415 413 $8K
72050 343 342 $8K
73552 1,034 868 $6K
72157 39 39 $6K
71010 809 497 $6K
73700 125 109 $5K
73718 52 49 $5K
72146 51 51 $5K
93975 46 42 $5K
72040 308 288 $4K
70545 68 68 $4K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 81 79 $4K
G9638 Final reports without documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) 5,901 4,550 $3K
76942 163 162 $3K
76506 145 99 $3K
70548 54 53 $3K
72070 230 226 $3K
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 45 44 $2K
70543 14 14 $2K
77012 27 27 $2K
93925 38 37 $2K
74170 20 15 $1K
71271 45 45 $1K
70544 38 36 $1K
99222 Initial hospital care, per day, moderate complexity 41 41 $1K
73080 112 97 $1K
77080 130 130 $1K
70547 24 24 $1K
76604 31 29 $988.79
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 12 12 $940.29
73090 112 94 $940.01
72131 13 13 $875.34
99215 Prolong outpt/office vis 12 12 $869.98
99233 Prolong inpt eval add15 m 25 14 $827.14
74000 91 47 $496.80
72170 106 99 $454.73
G9557 Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found 1,828 1,645 $434.33
73060 46 43 $335.41
73070 50 49 $306.84
50200 12 12 $278.79
74019 23 16 $272.73
99231 Subsequent hospital care, per day, straightforward or low complexity 15 13 $131.17
77073 15 14 $80.19
G9551 Final reports for imaging studies without an incidentally found lesion noted 1,599 1,379 $70.45
J3010 Injection, fentanyl citrate, 0.1 mg 12 12 $21.19
G9547 Cystic renal lesion that is simple appearing (bosniak i or ii) , or adrenal lesion less than or equal to 1.0 cm or adrenal lesion greater than 1.0 cm but less than or equal to 4.0 cm classified as likely benign by unenhanced ct or washout protocol ct, or mri with in- and opposed-phase sequences or other equivalent institutional imaging protocols 29 28 $0.03
3100F 31 28 $0.00
G9550 Final reports for imaging studies with follow-up imaging recommended, or final reports that do not include a specific recommendation of no follow-up 13 12 $0.00
3342F 70 70 $0.00